HCA Healthcare, Inc. HCA
506.04 USD +1.62 (+0.32%)
At closeNov 11, 2026, 4:00 PM EST
506.00 -0.04 -0.01%
After hours · Nov 11, 4:00 PM ET
493.59 Day range 506.04
353.99 52-week range 556.52
- YTD
- +8.39%
- 1 year
- +9.46%
News
benzinga.com Michael Burry’s Portfolio: What the ‘Big Short’ Investor Owns Now Michael Burry expanded bets on Lululemon, Adobe, Sprouts, PayPal, MercadoLibre and JD.com, favoring buybacks and beaten-down value stocks.
businesswire.com HCA Healthcare Named a Best Employer for Veterans by Military Times for Seventh Consecutive Year NASHVILLE, Tenn.,--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been recognized for the seventh consecutive year as…
globenewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA NEW YORK, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to…
benzinga.com Here's How Much $100 Invested In HCA Healthcare 15 Years Ago Would Be Worth Today HCA Healthcare (NYSE:HCA) has outperformed the market over the past 15 years by 9.26% on an annualized basis producing an average annual return of 21.98%. Currently, HCA Healthcare has a market…
zacks.com Take the Zacks Approach to Beat the Markets: Ulta Beauty, Accenture, HCA in Focus Zacks highlights how its research strategies have delivered strong returns, with ACN, HCA and ULTA among the standout performers.
fool.com HCA Healthcare: 3 Key Takeaways for Long-Term Investors Same facility equivalent admissions increased 3% in the third quarter. HCA Healthcare repurchased approximately $3 billion of outstanding shares.
zacks.com Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
prnewswire.com INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact…
247wallst.com Hospital Stocks Soared as Democrats Took Congress HCA posted its biggest one-day jump in four years before a single law changed. Wall Street is pricing in relief that needs Congress, a presidential signature, and a December funding fight to survive.
zacks.com HCA Healthcare (HCA) Just Flashed Golden Cross Signal: Do You Buy? HCA Healthcare (HCA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HCA broke through the 20-day moving average, which suggests a…
benzinga.com Truist Securities Reiterates Buy on HCA Healthcare, Raises Price Target to $510 Truist Securities analyst David Macdonald reiterates HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $510.
benzinga.com Here’s How Much You Would Have Made Owning HCA Healthcare Stock In The Last 15 Years HCA Healthcare (NYSE:HCA) has outperformed the market over the past 15 years by 8.97% on an annualized basis producing an average annual return of 21.51%. Currently, HCA Healthcare has a market…
benzinga.com Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $468 Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $381 to $468.
benzinga.com Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street Alphabet logs its worst week since 2011 and Intel its worst day ever as the AI trade cracks, while health care posts a record month against the market.
benzinga.com RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521 RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.
benzinga.com Barclays Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $401 Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $387 to $401.
benzinga.com TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $486 TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $460 to $486.
benzinga.com HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.
benzinga.com Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490 Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.- benzinga.com Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409 Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.
- benzinga.com B of A Securities Maintains Neutral on HCA Healthcare, Raises Price Target to $500 B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $450 to $500.
benzinga.com HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock HCA Healthcare beat Q3 2026 estimates and raised guidance, but shares slid following a $400 million pretax hit from rising uninsured patient volumes.
benzinga.com HCA Healthcare Q3 2026 Earnings Call Transcript HCA Healthcare (NYSE:HCA) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…- benzinga.com HCA Healthcare Raises FY2026 GAAP EPS Guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 Est; Raises FY2026 Sales Guidance from $77.000B-$79.500B to $78.250B-$79.500B vs $78.517B Est HCA Healthcare (NYSE:HCA) raises FY2026 GAAP EPS guidance from $28.70-$30.50 to $29.60-$30.50 vs $29.46 analyst estimate. Raises FY2026 sales outlook from $77.000 billion-$79.500 billion to $78.250…
benzinga.com Visa, Coca-Cola On Deck Tuesday As Payments Growth, Global Demand Face Test Visa is Tuesday’s most material report, with investors looking for continued payments growth after a strong run in the stock. Coca-Cola, HSBC Holdings, Novartis, Boeing and S&P Global report before…- benzinga.com TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $460 TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $431 to $460.
finance.yahoo.com What Really Drove HCA Stock Higher? HCA Healthcare (HCA) runs hospitals, urgent care facilities and ambulatory surgery centers. Its stock rose 107.8% before ...
- beckershospitalreview.com Hospital stocks spike after Congressional blue wave: WSJ Hospital stocks spike after midterm elections as Democrats win Congress, boosting Medicaid and ACA subsidy prospects, driving gains for major ...
tntribune.com Latrecia Jordan Elected National Recording Secretary of Jack and Jill of America Inc. NASHVILLE, TN — Latrecia Jordan, a longtime member of the Nashville Chapter of Jack and Jill of America, Incorporated, has ...
msn.com Hospital stocks are feeling blue, in a good way Plus, CoreWeave’s mixed signal, and OpenAi’s mounting losses.- barrons.com This Veteran Bond Manager Is Making the Most of Rising Yields. What She Likes Now. Bonds offer investors some of the most attractive yields in decades on a nominal and an inflation-adjusted basis, says Mary Ellen Stanek, managing director and chief investment officer emeritus at ...
msn.com Michael Burry’s portfolio: What the ‘Big Short’ investor owns now Michael Burry has been busy adding to positions in his portfolio. Across his two most recent Substack posts, the investor ...
kalkine.com.au High Court Upholds the ATO's Cancellation of a $56 Million Capital Loss From a Share Sale to a Family SMSF The High Court has handed the ATO one of its most significant anti-avoidance wins in years. In Commissioner of Taxation v ...
- markets.chroniclejournal.com AvionTEq Wraps Up a Successful NBAA-BACE 2026 and Announcement of the UTS100 Raffle Winner AvionTEq ends the NBAA-BACE 2026 at the Las Vegas Convention Center, Las Vegas, Nevada from October 20-22, 2026 successfully.
griffindailynews.com From high-flying AI stocks to tariff-hit alcohol companies, the midterms shook up Wall Street The overwhelming victory by the Democrats in the midterm elections shook up Wall Street this week. The biggest tremors were ...